Work

ERK1/2 Inhibition Overcomes Resistance to Venetoclax in AML By Altering Drp1-Dependent Mitochondrial Fission and Metabolism

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-167171

Authors: Priyanka Sharma, Sujan Piya, Natalia Baran, Anna Zal, Christopher J. Hindley, Kim-Hien Dao, Martin Sims, Tomasz Zal, Vivian Ruvolo, Michael Andreeff, Gautam Borthakur

Institutions: The University of Texas MD Anderson Cancer Center, Astex Pharmaceuticals

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310108466

FWCI: 0.182

Cites:

Cited by: 1

Related to: 10